The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial

BACKGROUND: Each year, worldwide about 530,000 women die from causes related to pregnancy and childbirth. Of the deaths 99% are in low and middle income countries. Obstetric haemorrhage is the leading cause of maternal mortality, most occurring in the postpartum period. Systemic antifibrinolytic age...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakur, Haleema, Elbourne, Diana, Gülmezoglu, Metin, Alfirevic, Zarko, Ronsmans, Carine, Allen, Elizabeth, Roberts, Ian
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864262/
https://www.ncbi.nlm.nih.gov/pubmed/20398351
http://dx.doi.org/10.1186/1745-6215-11-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864262/
https://www.ncbi.nlm.nih.gov/pubmed/20398351
http://dx.doi.org/10.1186/1745-6215-11-40

Ejemplares similares